Nutrition Intervention in Treating Women With Breast Cancer
- Conditions
- Breast Cancer
- Registration Number
- NCT00002564
- Lead Sponsor
- Institute for Cancer Prevention (IFCP)
- Brief Summary
RATIONALE: Dietary fat may be involved in the growth of cancer cells. Restricting dietary fat may help fight cancer.
PURPOSE: Randomized clinical trial to study the effectiveness of a low fat diet in treating postmenopausal women who have stage I, stage II, or stage IIIA breast cancer that has been completely removed by surgery.
- Detailed Description
OBJECTIVES: I. Determine whether dietary fat reduction will effectively prolong disease-free and overall survival in women surgically treated for early stage breast cancer who are receiving adjuvant therapy with or without either tamoxifen, cyclophosphamide, methotrexate, fluorouracil (CMF), doxorubicin, cyclophosphamide (AC), fluorouracil, doxorubicin, cyclophosphamide (FAC, CAF), or AC followed by paclitaxel. II. Evaluate whether differences in the lipid profile are associated with dietary group assignment and dietary fat.
OUTLINE: This is a randomized, multicenter study. Patients are stratified by center, nodal status, ER status, and type of adjuvant chemotherapy. The first group receives intensive dietary intervention for reduction of total fat intake to 15% of calories, with repeated individual and group counseling sessions. The second group receives USDA/DHHS dietary guidelines and minimal intervention. All patients who are estrogen receptor positive receive concurrent therapy with tamoxifen; cyclophosphamide, methotrexate, fluorouracil (CMF) followed by tamoxifen; doxorubicin, cyclophosphamide (AC) followed by tamoxifen; fluorouracil, doxorubicin, cyclophosphamide (FAC, CAF) followed by tamoxifen; or AC, paclitaxel followed by tamoxifen. Patients are followed annually throughout the study.
PROJECTED ACCRUAL: Approximately 2,500 women will be accrued for this study.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 2500
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (37)
Memorial Sloan-Kettering Cancer Center
๐บ๐ธNew York, New York, United States
Cedars-Sinai Medical Center
๐บ๐ธLos Angeles, California, United States
Palm Beach Oncology-Hematology at the Good Samaritan Medical Center
๐บ๐ธWest Palm Beach, Florida, United States
St. Barnabas Medical Center
๐บ๐ธLivingston, New Jersey, United States
North Shore University Hospital
๐บ๐ธManhasset, New York, United States
Geisinger Medical Center
๐บ๐ธDanville, Pennsylvania, United States
Cancer Research Center of Hawaii
๐บ๐ธHonolulu, Hawaii, United States
University of Alabama Comprehensive Cancer Center
๐บ๐ธBirmingham, Alabama, United States
Virginia Piper Cancer Institute
๐บ๐ธMinneapolis, Minnesota, United States
Sylvester Cancer Center, University of Miami
๐บ๐ธMiami, Florida, United States
Barbara Ann Karmanos Cancer Institute
๐บ๐ธDetroit, Michigan, United States
Duke Comprehensive Cancer Center
๐บ๐ธDurham, North Carolina, United States
John Wayne Cancer Institute
๐บ๐ธSanta Monica, California, United States
Arizona Cancer Center
๐บ๐ธTucson, Arizona, United States
Baptist Regional Cancer Institute - Jacksonville
๐บ๐ธJacksonville, Florida, United States
Women to Women
๐บ๐ธYarmouth, Maine, United States
Chao Family Comprehensive Cancer Center
๐บ๐ธOrange, California, United States
Sharp Healthcare - Murrieta
๐บ๐ธMurrieta, California, United States
Bennett Cancer Center
๐บ๐ธStamford, Connecticut, United States
Evanston Northwestern Health Care
๐บ๐ธEvanston, Illinois, United States
Fred Hutchinson Cancer Research Center
๐บ๐ธSeattle, Washington, United States
Lombardi Cancer Center, Georgetown University
๐บ๐ธWashington, District of Columbia, United States
Texas Oncology, P.A.
๐บ๐ธDallas, Texas, United States
Jonsson Comprehensive Cancer Center, UCLA
๐บ๐ธLos Angeles, California, United States
Permanente Medical Group (060)
๐บ๐ธOakland, California, United States
Shands Cancer Center
๐บ๐ธGainesville, Florida, United States
Midwestern Regional Medical Center
๐บ๐ธZion, Illinois, United States
Beth Israel Deaconess Medical Center
๐บ๐ธBoston, Massachusetts, United States
University of Iowa Hospitals and Clinics
๐บ๐ธIowa City, Iowa, United States
American Health Foundation
๐บ๐ธNew York, New York, United States
Surgical Associates
๐บ๐ธAlbuquerque, New Mexico, United States
Arthur G. James Cancer Hospital - Ohio State University
๐บ๐ธColumbus, Ohio, United States
Kaiser Permanente Center for Health Research
๐บ๐ธPortland, Oregon, United States
Spohn Hospital South
๐บ๐ธCorpus Christi, Texas, United States
Medical University of South Carolina
๐บ๐ธCharleston, South Carolina, United States
Medical College of Wisconsin
๐บ๐ธMilwaukee, Wisconsin, United States
Rhode Island Hospital
๐บ๐ธProvidence, Rhode Island, United States